Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biological membranes and cellular lipid pools are fundamental structural components that define the boundaries of cells and organelles, providing a semi-permeable barrier and a platform for biochemical signaling (Nature Reviews Molecular Cell Biology, 2006). They consist primarily of phospholipids, sterols, and sphingolipids organized into bilayers that maintain cellular homeostasis and compartmentalization (Wikipedia, "Cell membrane"). In pharmacology, these structures are targeted by various anti-infective agents that exploit differences between host and pathogen lipid compositions, such as polyene antifungals like Amphotericin B which bind to ergosterol (PubChem, CID 5280965). Similarly, lipopeptide antibiotics like Daptomycin insert into bacterial membranes to cause rapid depolarization and cell death (NCBI, PMC4159391). Beyond infections, alterations in lipid pool dynamics and membrane fluidity are implicated in the pathogenesis of metabolic syndromes, neurodegenerative diseases, and cancer (Journal of Lipid Research, 2012). Therapeutic strategies targeting these components often face challenges regarding selectivity to avoid systemic toxicity and hemolysis in the host (StatPearls, "Polymyxin B"). These targets are unique because they are often addressed through physical-chemical interactions rather than specific lock-and-key protein binding. Overall, they represent a broad but vital class of non-proteinaceous therapeutic targets in modern medicine.
Direct disruption of the lipid bilayer, formation of transmembrane pores, or sequestration of specific lipid species to alter membrane permeability and signaling.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular lipid pools and biological membranes.